Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Robinet

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Alimentary Pharmacology & Therapeutics|October 1, 1996
Treatment of severe Crohn's disease with anti-CD4 monoclonal antibodyV Canva-Delcambre, S Jacquot, E Robinet, et al.
Hematology and Cell Therapy|October 1, 1996
[Utilization of herpes simplex virus-1 thymidine kinase gene in stem cell transplantation therapy]P Tiberghien, J Y Cahn, C Ferrand, et al.
Gene Therapy|November 14, 2014
Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-conceptC Leboeuf, J Roser-Schilder, M Lambotin, et al.
Blood|January 3, 2001
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graftP Tiberghien, C Ferrand, B Lioure, et al.
Oncogene|September 15, 2015
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease developmentA-L Joly, A Deepti, A Seignez, et al.
Oncogene|June 3, 2016
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease developmentA-L Joly, A Deepti, A Seignez, et al.
European Cytokine Network|September 1, 1996
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantationB Bonnotte, A M Burdiles, J Chehimi, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Alimentary Pharmacology & Therapeutics|October 1, 1996
Treatment of severe Crohn's disease with anti-CD4 monoclonal antibodyV Canva-Delcambre, S Jacquot, E Robinet, et al.
Hematology and Cell Therapy|October 1, 1996
[Utilization of herpes simplex virus-1 thymidine kinase gene in stem cell transplantation therapy]P Tiberghien, J Y Cahn, C Ferrand, et al.
Gene Therapy|November 14, 2014
Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-conceptC Leboeuf, J Roser-Schilder, M Lambotin, et al.
Blood|January 3, 2001
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graftP Tiberghien, C Ferrand, B Lioure, et al.
Oncogene|September 15, 2015
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease developmentA-L Joly, A Deepti, A Seignez, et al.
Oncogene|June 3, 2016
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease developmentA-L Joly, A Deepti, A Seignez, et al.
European Cytokine Network|September 1, 1996
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantationB Bonnotte, A M Burdiles, J Chehimi, et al.
Pageof 4